TCT CONNECT-271 The MeRes-1 Extend Trial: 2-Year Clinical and 6-Month Imaging Outcomes of Thin-Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions

Article2018

TCT-64 Two-Year Clinical and Imaging Outcomes of Thin Strut Sirolimus-Eluting Bioresorbable Vascular Scaffolds in De Novo Coronary Artery Lesions: The MeRes-1 Trial

Ashok Seth, Yoshinobu Onuma, Ricardo A. Costa, Praveen Chandra, Vinay K. Bahl, Cholenahally Nanjappa Manjunath, Ajaykumar Umakant Mahajan, Viveka Kumar, Parvin Kumar Goel, Gurpreet Singh Wander, Samuel R. Mathews, Upendra Kaul, Ajit Kumar Valaparambil, Pratap Chandra Rath, Vijay Trehan, Sengottuvelu Gunasekaran, Sundeep Mishra, Alexandre Abizaid, Patrick W. Serruys

Journal of the American College of Cardiology

Article2020

Imaging and 2‐year clinical outcomes of thin strut <scp>sirolimus‐eluting</scp> bioresorbable vascular scaffold: The <scp>MeRes</scp>‐1 extend trial

Alexandre Abizaid, Saško Kedev, Rosli Bin Mohd Ali, Teguh Santoso, Ángel Cequier, Robert‐Jan Van Geuns van Geuns, Bernard Chevalier, Farrel Hellig, Ricardo A. Costa, Yoshinobu Onuma, J. Ribamar Costa, Patrick W. Serruys, Sripal Bangalore

Catheterization and Cardiovascular Interventions

Article2019

Three-year clinical and two-year multimodality imaging outcomes of a thin-strut sirolimus-eluting bioresorbable vascular scaffold: MeRes-1 trial

Ashok Seth, Yoshinobu Onuma, Praveen Chandra, Vinay K. Bahl, Cholenahally Nanjappa Manjunath, Ajaykumar Umakant Mahajan, Viveka Kumar, Praveen Goel, Gurpreet Singh Wander, Upendra Kaul, V K Ajit Kumar, Alexandre Abizaid, Patrick W. Serruys

EuroIntervention

Article2019

TCT-186 Preclinical Evaluation of a Novel Thin-Strut PLLA Bioresorbable Scaffold in Porcine Coronary Artery at 6-Month Follow-Up

Kuniaki Takahashi, Yuki Katagiri, Mariusz Tomaniak, Ply Chichareon, Rodrigo Modolo, Norihiro Kogame, Chun‐Chin Chang, Masafumi Ono, Hideyuki Kawashima, Chao Gao, Nial Bullett, Naveed Ahmed, Kadem Al-Lameé, Rasha Al‐Lamee, Patrick W. Serruys, Yoshinobu Onuma

Journal of the American College of Cardiology

Article2010

Three-year results of clinical follow-up after a bioresorbable everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB trial

Yosinobu Onuma, Patrick W. Serruys, John A. Ormiston, Evelyn Regar, Mark Webster, Leif Thuesen, Dariusz Dudek, Susan Veldhof, Richard Rapoza